Latest Macular degeneration Stories
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
TARRYTOWN, N.Y., Dec. 1, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S.
From dry eyes to glaucoma, brand stands out in the marketplace with special formulas Boca Raton, FL (PRWEB) November 24, 2014 Doctor’s Advantage Products,
National research foundation will host FREE seminars in Naples and Palm Beach Gardens on age-related macular degeneration to provide information on the latest research, treatment and technology for
CRESTWOOD, Ky., Nov. 20, 2014 /PRNewswire/ -- Apellis Pharmaceuticals announced today that it entered into an agreement to acquire Potentia Pharmaceuticals.
Brand’s effective supplements for better eye care available on RevNutrition.com Boca Raton, FL (PRWEB) November 19, 2014 As we head into the winter
TARRYTOWN, N.Y., Nov. 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd.
A team of researchers from Israel and the UK are looking to add to the number of medical devices that can be used to treat visual impairments by developing a new prosthetic unit for use by retinal degeneration patients.
BOCA RATON, Fla., Nov.
ST. LOUIS, Nov.
- A trick or prank.